Advertisement

Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques

  • Authors
  • C. R. Pfaltz
  • Robert B. McCall
  • Ray W. Fuller
  • Richard M. Schultz
  • David A. Solomon
  • Edison Miyawaki
  • Carl Salzman
  • Philip J. Podrid
  • Lisa Mendes
  • Scott L. Beau
  • John S. Wilson
  • Donald T. Witiak
  • Youg Wei
  • Satyavan Sharma
  • Alberto Mantovani
  • Annunciata Vecchi
  • Pushkar N. Kaul
  • Ernst Jucker

Part of the Progress in Drug Research book series (PDR, volume 35)

Table of contents

  1. Front Matter
    Pages 1-7
  2. Ray W. Fuller
    Pages 85-108
  3. Richard M. Schultz
    Pages 109-138
  4. David A. Solomon, Edison Miyawaki, Carl Salzman
    Pages 139-149
  5. Philip J. Podrid, Lisa Mendes, Scott L. Beau, John S. Wilson
    Pages 151-247
  6. Donald T. Witiak, Yong Wei
    Pages 249-363
  7. Satyavan Sharma
    Pages 365-485
  8. Alberto Mantovani, Annunciata Vecchi
    Pages 487-519
  9. Pushkar N. Kaul
    Pages 521-557
  10. Back Matter
    Pages 559-614

About this book

Introduction

Volume 36 of "Progress in Drug Research" contains 5 articles and the various indexes which facilitate its use and establish the connec­ tion with the previous volumes. While all articles deal with some of the topical aspects of drug research, the contribution by Robert R. Ruffolo et al. on "Drug receptors and control of the cardiovas­ cular system: Recent advances" is indeed in its own right a mono­ graphic presentation of this important domain. The remaining four reviews provide an overview of the work in­ volved in the search for new and better medicines, with a focus on chemical, pharmacological, toxicological, biological, biochemical and molecular modeling studies. In the 31 years this series has existed, the Editor has enjoyed the help and advice of many colleagues. Readers, the authors of the in­ dividual articles, and, last but not least, the reviewers have all con­ tributed greatly to the success of PDR. Although many comments received have been favorable, it is nevertheless necessary to analyze and to reconsider the current position and the direction of such a series. So far, it has been the Editor's aim to help spread informa­ tion on the vast domain of drug research, and to provide the reader with a tool helping him or her to keep abreast of the latest develop­ ments and trends.

Keywords

Arzneimittel Arzneimittelforschung drug drug discovery drug research research

Editors and affiliations

  • Ernst Jucker
    • 1
  1. 1.BaselSchweiz

Bibliographic information

Industry Sectors
Biotechnology